Australia markets closed

Ionis Pharmaceuticals, Inc. (IONS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
38.24+0.87 (+2.33%)
At close: 4:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
707,504
729,264
1,122,599
599,674
507,666
Cost of revenue
11,977
11,947
4,384
1,820
374,644
Gross profit
695,527
717,317
1,118,215
597,854
133,022
Operating expenses
Research development
557,926
535,077
465,688
414,604
374,644
Selling general and administrative
336,400
354,300
286,644
244,622
108,488
Total operating expenses
894,326
889,377
752,332
659,226
483,132
Operating income or loss
-198,799
-172,060
365,883
-61,372
24,534
Interest expense
44,990
44,990
48,768
44,789
44,752
Total other income/expenses net
37,206
47,040
29,654
30,005
-3,058
Income before tax
-206,817
-170,032
346,769
-76,156
-23,276
Income tax expense
319,936
316,734
43,507
-291,141
-5,980
Income from continuing operations
-526,753
-486,766
303,262
214,985
-17,296
Net income
-501,527
-451,286
294,146
273,741
-5,970
Net income available to common shareholders
-501,650
-451,487
296,563
276,868
9,661
Basic EPS
-
-
2.12
2.09
0.08
Diluted EPS
-
-
2.08
2.07
0.08
Basic average shares
-
-
140,000
132,320
124,016
Diluted average shares
-
-
143,000
134,056
126,098
EBITDA
-
-107,882
411,531
-18,839
29,825